Secondary analysis of EARLY TAVR (901 patients with asymptomatic severe aortic stenosis): no interaction between age and the effect of early TAVR vs clinical surveillance on death, stroke or unplanned cardiovascular hospitalisation; benefit was consistent from 65 to ≥80 years.
Secondary analysisn = 901
Goel et al. Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial